Related Experiment Video
Updated: May 19, 2026
11:08
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Induced pluripotent stem cells as platforms for engineering NK cell immunotherapies
Anna Jezierski1,2,3, Jez Huang1, Lea Desbiens1,3
1Human Health Therapeutics Research Center, Translational Biosciences, National Research Council of Canada, Ottawa, ON, Canada.
Frontiers in Cell and Developmental Biology
|May 18, 2026
Summary
Human induced pluripotent stem cells (iPSCs) offer a scalable, off-the-shelf solution for adoptive cell therapy. iPSC-derived natural killer (iNK) cells are programmable for enhanced efficacy and persistence in cancer treatment.
Area of Science:
- Immunology
- Stem Cell Biology
- Cancer Therapy
Background:
- Human induced pluripotent stem cells (iPSCs) possess self-renewal and differentiation capabilities, making them ideal for cell therapy.
- Current cell therapies face limitations due to manufacturing complexity, variable quality, and donor restrictions.
- iPSC technology enables the development of standardized, off-the-shelf immune effector cells.
Purpose of the Study:
- To review the advancements and future directions of iPSC-derived natural killer (iNK) cell therapies.
- To highlight the advantages of iPSC platforms for creating programmable, off-the-shelf immunotherapies.
- To discuss the potential of iNK cells in transforming cancer treatment.
Main Methods:
- Utilizing CRISPR/Cas-based editing to introduce functional traits into iPSCs and progenitor cells.
- Developing standardized manufacturing pipelines for iNK cell therapy products.
- Leveraging iPSC master cell banks for consistent starting material.
Main Results:
- iPSC-derived NK cells (iNK) demonstrate clinical feasibility, safety, and therapeutic potential.
- Genome engineering allows for customizable iNK cell potency, persistence, and resistance to inhibitory signals.
- Programmable iPSC platforms facilitate modular and targeted immunotherapies.
Conclusions:
- iPSC technology is revolutionizing adoptive cell therapy by enabling scalable, off-the-shelf solutions.
- Programmable iNK cells offer a promising avenue for enhanced cancer immunotherapy.
- Continued refinement of protocols and manufacturing is crucial for clinical success.
Keywords:
chimeric antigen receptor (CAR)genome engineeringimmunotherapyinduced pluripotent stem (iPS) cellsnatural killer cellsMore Related Videos
Related Concept Videos
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...